Post-approval studies (Phase 4)Study completedNCT02415400
What this trial is testing
Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Who this might be right for
Acute Coronary Syndromes
Bristol-Myers Squibb 4,614